BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23673268)

  • 1. GLP-2 and mesenteric blood flow.
    Hansen LB
    Dan Med J; 2013 May; 60(5):B4634. PubMed ID: 23673268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients.
    Bremholm L; Hornum M; Andersen UB; Hartmann B; Holst JJ; Jeppesen PB
    Regul Pept; 2011 Jun; 168(1-3):32-8. PubMed ID: 21421014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters.
    Bremholm L; Hornum M; Andersen UB; Holst JJ
    Regul Pept; 2010 Jan; 159(1-3):67-71. PubMed ID: 19900491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-2 increases mesenteric blood flow in humans.
    Bremholm L; Hornum M; Henriksen BM; Larsen S; Holst JJ
    Scand J Gastroenterol; 2009; 44(3):314-9. PubMed ID: 19005872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.
    Naimi RM; Madsen KB; Askov-Hansen C; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
    Regul Pept; 2013 Jun; 184():47-53. PubMed ID: 23501043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.
    Taylor-Edwards CC; Burrin DG; Holst JJ; McLeod KR; Harmon DL
    J Dairy Sci; 2011 Feb; 94(2):888-98. PubMed ID: 21257057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Hornum M; Pedersen JF; Larsen S; Olsen O; Holst JJ; Knop FK
    Pancreatology; 2010; 10(2-3):201-7. PubMed ID: 20460948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
    Madsen KB; Askov-Hansen C; Naimi RM; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
    Regul Pept; 2013 Jun; 184():30-9. PubMed ID: 23511332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients.
    Høyerup P; Hellström PM; Schmidt PT; Brandt CF; Askov-Hansen C; Mortensen PB; Jeppesen PB
    Regul Pept; 2013 Jan; 180():12-6. PubMed ID: 23159451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of glucagon-like peptide 2-induced blood flow: responses in different vascular sites.
    Deniz M; Bozkurt A; Kurtel H
    Regul Pept; 2007 Jul; 142(1-2):7-15. PubMed ID: 17346812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of glucagon-like peptide-1, GLP-1
    Bremholm L; Andersen UB; Hornum M; Hilsted L; Veedfald S; Hartmann B; Holst JJ
    Physiol Rep; 2017 Feb; 5(4):. PubMed ID: 28235974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.
    Drucker DJ; Yusta B
    Annu Rev Physiol; 2014; 76():561-83. PubMed ID: 24161075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjects.
    Trahair LG; Horowitz M; Hausken T; Feinle-Bisset C; Rayner CK; Jones KL
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2628-34. PubMed ID: 25210879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the human splanchnic circulation in pressor response induced by handgrip contraction.
    Waaler BA; Toska K; Eriksen M
    Acta Physiol Scand; 1999 Jun; 166(2):131-6. PubMed ID: 10383492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.
    Piscaglia F; Zironi G; Gaiani S; Mazziotti A; Cavallari A; Gramantieri L; Valgimigli M; Bolondi L
    Hepatology; 1999 Jul; 30(1):58-64. PubMed ID: 10385639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenoldopam mesylate infusion on splanchnic perfusion after myocardial revascularization on cardiopulmonary bypass: an ultrasound Doppler study.
    Meco M; Allaz MC; Cirri S
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):642-6. PubMed ID: 21109463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of variations in duodenal glucose load on blood pressure, heart rate, superior mesenteric artery blood flow and plasma noradrenaline in healthy young and older subjects.
    Trahair LG; Vanis L; Gentilcore D; Lange K; Rayner CK; Horowitz M; Jones KL
    Clin Sci (Lond); 2012 Mar; 122(6):271-9. PubMed ID: 21942924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory responses to a meal in patients with a newly transplanted heart.
    Waaler BA; Hisdal J; Eriksen M
    Acta Physiol Scand; 2002 Feb; 174(2):101-8. PubMed ID: 11860371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenteric blood flow velocity and its relation to circulatory adaptation during the first week of life in healthy term infants.
    Martinussen M; Brubakk AM; Linker DT; Vik T; Yao AC
    Pediatr Res; 1994 Sep; 36(3):334-9. PubMed ID: 7808830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.
    Holst JJ; Hartmann B; Gottschalck IB; Jeppesen PB; Miholic J; Henriksen DB
    Scand J Gastroenterol; 2007 Jul; 42(7):814-20. PubMed ID: 17558904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.